Protagonist Therapeutics Inc (PTGX)

Quick ratio

		Mar 31, 2024	Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019
Cash	US$ in thousands	172,568	186,727	230,527	235,382	127,686	125,744	152,816	120,237	98,477	123,665	120,542	192,412	83,000	117,358	83,625	146,242	60,215	33,006	50,195	71,143
Short-term investments	US$ in thousands	150,067	154,890	90,224	78,019	103,073	111,611	114,621	171,653	206,800	203,235	193,759	161,868	190,500	188,500	110,349	62,423	57,298	100,011	87,497	54,958
Receivables	US$ in thousands	—	—	—	50	51	3,852	620	3,363	28,504	5,333	4,509	9,855	5,819	3,821	3,324	3,273	3,747	7,499	2,118	6,310
Total current liabilities	US$ in thousands	39,910	21,274	27,867	26,398	23,229	31,179	36,754	40,088	43,456	44,016	39,156	42,973	34,515	40,241	38,563	35,360	36,372	35,406	30,776	33,323
Quick ratio		8.08	16.06	11.51	11.87	9.94	7.74	7.29	7.37	7.68	7.55	8.14	8.47	8.09	7.70	5.12	5.99	3.33	3.97	4.54	3.97

March 31, 2024 calculation

Quick ratio = (Cash + Short-term investments + Receivables) ÷ Total current liabilities
= ($172,568K + $150,067K + $—K) ÷ $39,910K
= 8.08

The quick ratio of Protagonist Therapeutics Inc has shown fluctuations over the periods analyzed. The quick ratio indicates the company's ability to meet its short-term obligations with its most liquid assets.

From Dec 31, 2019, to Mar 31, 2024, the quick ratio ranged from a low of 3.33 to a high of 16.06. The quick ratio generally remained above the ideal value of 1, indicating that Protagonist Therapeutics Inc has a strong ability to cover its short-term liabilities with its current liquid assets.

The quick ratio experienced a significant increase from Sep 30, 2020, to Dec 31, 2023, indicating strengthening liquidity position during this period. However, there were fluctuations in the quick ratio over other periods, suggesting variations in the company's ability to quickly cover its short-term obligations.

Overall, the trend of the quick ratio for Protagonist Therapeutics Inc reflects a generally healthy liquidity position, with some fluctuations indicating changing levels of short-term financial strength during the periods analyzed.